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Introduction  33 
Medicines, specifically analgesics, are the most commonly misused substances in the 34 
US after cannabis and alcohol (1). In the UK, concern around misuse of analgesics 35 
has been growing (2), in part owing to a steady rise in the number of deaths related to 36 
tramadol (3). Similar concerns exist for other medicines, with an estimated 1.5 million 37 
people addicted to benzodiazepines (4) and rising deaths associated with these 38 
medicines (3). A series of reviews assert that those with an addiction to medicines 39 
(ATM) are gravely underrepresented at UK addiction treatment services (2, 5, 6), 40 
although prevalence data are limited. It is likely that a large number of people in the 41 
UK with ATM are not receiving the support they need and may be at risk from a range 42 
of health concerns. It is suggested that those affected are a diverse group, including 43 
those with a history of illicit substance use disorders, psychiatric conditions or a poor 44 
knowledge regarding the harms of non-therapeutic use (2, 7).  45 
To increase understanding of the extent and nature of the problem, this study 46 
investigates the experiences of health professionals in primary care who are likely to 47 
come into contact with people with ATM. This study aimed to explore the experiences 48 
of health professionals within General Practice (GP) and community pharmacy 49 
settings with respect to patients with ATM. 50 
Methods 51 
An online survey was developed from previous work (8, 9) and disseminated to health 52 
professionals in primary care in Northwest England. Eight of nine Local Authorities 53 
approached agreed to support snowball recruitment and disseminate the survey to 54 
GPs and pharmacies, which was initiated in May 2015. A maximum of one health 55 
professional from each site participated in the research. The survey examined the 56 
frequency health professionals encounter individuals with ATM and their confidence 57 
and experiences with tackling these addictions. As this was an exploratory study, no 58 
statistical analysis was undertaken. The study was approved by the institutional 59 
Research Ethics Committee. 60 
Results  61 
Seventy-six health professionals completed the survey, including 35 general 62 
practitioners, 19 pharmacists, three nurse prescribers, two pharmacy technicians and 63 
one pharmacy dispenser (role missing for 16 participants). 64 
Two thirds of participants (66%, 48/73) reported suspecting a patient (including both 65 
patients and customers in the GP and pharmacy setting) has or is developing ATM on 66 
a weekly or more frequent basis, and a minority (12%, 9/75) stated that patients admit 67 
ATM with the same frequency. Over three quarters of participants reported feeling 68 
‘very’ or ‘fairly’ confident in: identifying individuals who are developing an addiction 69 
(76%, n= 47/62), initiating a conversation with patients about this (80%, n=50/63) and 70 
refusing access to medicines where appropriate (86%, n=54/63) (Figure 1). However, 71 
in contrast to the rate that they suspect ATM, only a minority (17%, 27/63) reported 72 
initiating a conversation regarding this, or refusing access to medicine (25%, 16/63), 73 
on a weekly or more frequent basis.  74 
<<Insert Figure 1 here>> 75 
ATM was suspected on a weekly or more frequent basis for: anxiolytics and hypnotics 76 
(53%, n=40/75), weak (47%, n=32/ 68) and strong (39%, n=27/70) opioid analgesics, 77 
and anti-epileptics and neuropathic analgesics (26%, n=17, 65) (Figure 2).  78 
<<Insert Figure 2 here>> 79 
Participants were asked to describe patients in whom they identified ATM. Amongst 80 
responses (n=55), common themes were that ATM relating to anxiolytics and 81 
hypnotics, opioid analgesics, anti-epileptic and neuropathic analgesics tended to 82 
involve middle-aged or older individuals with a history of chronic pain or mental health 83 
issues such as depression and anxiety. Addiction to antihistamines was also 84 
commonly associated with this population and linked with sleep disorders. Addiction 85 
to anxiolytics and hypnotics, opioid analgesics and stimulants were linked to younger 86 
people who were also using illicit substances or engaging in pleasure seeking 87 
behaviour. 88 
Discussion  89 
This study contributes further evidence that ATM is a significant public health issue in 90 
the UK, and highlights that there is likely to be a significant population of individuals 91 
with untreated ATM amongst those prescribed or purchasing medicines. In line with 92 
recent evidence (5) the most frequently suspected addictions in this study include 93 
anxiolytics and hypnotics (e.g. benzodiazepines and z-drugs), strong and weak opioid 94 
analgesics (e.g. tramadol & codeine), and anti-epileptic/neuropathic analgesics (e.g. 95 
pregabilin) suggesting that medicines containing codeine are likely to be of concern. 96 
This study adds to the international evidence base suggesting that the frequency with 97 
which health professionals take action when they suspect ATM is suboptimal and 98 
affected individuals may be at risk of harm through continued non-therapeutic use of 99 
these substances without diagnosis, support or treatment (6). 100 
Respondents identified ATM amongst a diverse range of individuals supporting prior 101 
work that reported populations at risk to include those using medication to manage 102 
chronic pain and psychological problems (7), young people intentionally using 103 
medications for recreational purposes (10) and individuals with other substance use 104 
problems including with alcohol and/or illicit drugs (2). Evidence suggests that many 105 
individuals affected by ATM may not typically identify as a ‘drug user’ (6) with 106 
implications for diagnosis and treatment as individuals may not view their medicines 107 
use as harmful or requiring treatment, or may be unwilling to seek support in drug 108 
treatment settings.  109 
The main limitation of this study is the number and geographic spread of the survey 110 
participants. However, the diverse health professionals included in the survey, and 111 
inclusion of both Community Pharmacy and General Medical Practice, provide 112 
confidence that the findings are not isolated to one locality/setting. Also, as ATM 113 
issues have been documented in a multiple studies from other parts of the UK and 114 
beyond, it is not unreasonable to conclude that the experiences reported are 115 
representative.  116 
Conclusion  117 
Findings from this study suggest that health professionals frequently suspect ATM 118 
amongst patients including a range of individuals, but in many cases suspected 119 
addiction goes unchallenged. Further research is needed to identify effective 120 
approaches to support health professionals to tackle ATM and to enable effective 121 
delivery of treatment services to this diverse group of individuals for whom traditional 122 
addiction services may not be attractive or suitable.  123 
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Responses to reviewer comments 
We thank the reviewers for their thoughtful and detailed comments and have attempted to address each of them in the table below. We have highlighted the 
altered text in the resubmitted manuscript, but quite a lot of additional text was revised to remain within word limits. We believe that the revised version is much 
improved and reports our findings in a clear and concise manner, which we hope will be of interest to the readers of the Journal of Addictive Diseases. 
Comment # Reviewer comment Detail of amendment/ response 
REVIEWER 1 
1 Little more about why experiences of GPs are needed? 
 
We have added the following text in lines 16-17 to make this clear: 
“Experiences of GP and Pharmacy staff were sought due to their role as gatekeepers to 
medicines”. 
2 Also, aim was to "...explore the experiences of health professionals…". 
This is vague. 
Updated in lines 14-16 to make the study aims clearer: 
“This study aimed to explore the frequency that health professionals within General 
Practice (GP) and community pharmacy settings suspect and respond to ATM and their 
perceptions about patients with ATM” 
3 The survey measure was not described. Without a more thorough 
description of the measure and its development, it is difficult to know 
the validity of the results. I would suggest listing sample items from the 
main domains of the survey (e.g., frequency of health professional 
contact with individuals with ATM; confidence and experience 
addressing ATM). 
 
Added detail regarding topics covered in the survey in lines 22-26. 
“…the survey, which examined: how frequently health professionals suspect patients to 
have addiction to different medicines; how frequently action is taken following such 
suspicion; and confidence in identifying and responding to ATM. Participants were also 
asked in open questions regarding characteristics of patients they suspected of ATM, 
and the medicines involved”. 
4 What was the total possible N for the study? If 76 individuals, each from 
a different site, completed the survey, how many possible sites were 
there? 
We are unable to report the total possible N. Each local authority public health team 
disseminated the survey to GPs and pharmacies in their region (clarified in line 21) but 
owing to an error in the protocol, data were not collected on how many sites they had 
disseminated the survey to and this information is not available. In the limitations (lines 
87-88) we have highlighted this to the reader. 
5 The statement, "As this was an exploratory study, no statistical analysis 
was undertaken", is insufficient. Better to describe what was done and 
why such an approach was appropriate to the research aims. 
The text has been modified in lines 27-28 to now read: 
“Frequencies and valid proportions of responses are reported, but the sample size 
precluded subgroup analysis by role” 
6 This sentence is unclear: "Two-thirds of participants reported suspecting 
a patient has or is developing ATM on a weekly or more frequent 
basis…". Does this mean that two-thirds of participants suspect at least 
1 patient they interacted with in the past week has ATM? 
To clarify, the text has been updated in line 34-35 to read: 
“Two thirds of participants (66%, 48/73) reported suspecting ATM in one or more 
patients on a weekly or more frequent basis” 
7 The results in lines 38-44 (and other places as well) report an N of 62 
and 63 - why are the other 13 or 14 participants not included? 
To clarify this, the following text has been added in line 27. 
“Frequencies and valid proportions of responses are reported”. 
8 The following is mentioned in the Results: "Participants were asked to 
describe patients in whom they identified ATM." Was this an open-
ended question? If so, more detail is needed about how the results were 
derived. 
This has been addressed in the additional detail provided regarding the nature of the 
questionnaire, as described in the response to comment #3. 
9 The most compelling finding of the study is that health professionals 
frequently suspect but do not address possible ATM. This should be 
emphasized in the Results and Discussion, and the overall manuscript 
would be much stronger if this became the focal point. 
We agree that this finding is particularly of interest and had become lost slightly. We 
have updated the title of the paper and emphasised this finding through additional text 
in the discussion and re-ordering the results. 
10 This section (discussion) needs to be reduced so that the measure can 
be better described. 
The Discussion extends beyond the scope of the survey in line 71 when 
the authors state, "Respondents identified ATM amongst a diverse 
range of individuals…". In reality, ATM was only suspected, and it cannot 
me be known whether any of the individuals actually suspected of ATM 
actually had it. 
We have amended the text in line 70 to read: 
“Respondents suspected ATM amongst…” 
A number of amendments have been made to the text in response to this and other 
comments to make clear that the article is examining suspected addiction rather than 
any attempt to identify a firm diagnosis. 
11 The limitations paragraph should be extended. For example, the role 
(e.g., GP, pharmacist) was not known for 21% of the sample. Also, it 
should be emphasized that these results are for individuals suspected of 
ATM, and that actual ATM could be more or less frequent.  
 
The limitations are now discussed in more detail (lines 75-88) to address both these 
points and others raised elsewhere. 
REVIEWER 2 
12 the sentence beginning on line 35 should be reworded to remove any 
ambiguity as to its intent (eg, was the suspicion of ATM on a weekly or 
more frequent basis or was the development of ATM on a weekly or 
more frequent basis?) 
To clarify, the text has been updated in line 34-35 to read: 
“Two thirds of participants (66%, 48/73) reported suspecting ATM in one or more 
patients on a weekly or more frequent basis” 
13 I would suggest replacing reference 1 with something a bit more current 
than 16-year-old citation, especially when referencing a 
contemporaneous phenomenon. 
The reference was from 2015 – this was our mistake. This particular reference has now 
been removed and all references have now been checked for accuracy. 
REVIEWER 3 
14 While ATM may be an accepted abbreviation in Europe it is not in the 
United States, and in fact searching the internet for "ATM" and 
"addiction" the most frequent hits are for an "addiction" to using ATMs 
(automated teller machines).  Thus, I suggest coming up with a different 
terminology so that the article is more globally understood. 
Despite extensive literature review, we were unable to find an accepted wide-spread 
term for this phenomenon and believe that we have described the term ‘addiction to 
medicine’ and its meaning clearly, along with defining the abbreviation in the article 
abstract and introduction. If the reviewer is able to suggest a more appropriate term or 
abbreviation that is in wide use, we would be happy to revisit this point. 
15 the title includes "and over the counter medicines", yet which medicines 
are OTC is not clarified in the article.  What is OTC in the EU is likely far 
different from what is OTC in the US. 
We agree that this distinction may cause confusion to an international readership and 
have removed the terms ‘prescription medicine’ and ‘over the counter medicines’ from 
the article title and text as the focus on this work was any medicine to which the 
respondents were acting as gatekeepers. We have further clarified in the study aims 
that the survey examined medicines that were prescribed or purchased over the 
counter medicine (as detailed in the response to comment #2). 
16 Line 5: Abbreviation should be spelled out the first time they are used, 
e.g., US and UK in the first paragraph of the article. 
The text has been updated to address this (lines 5 & 8). 
17 references that are more than 4-5 years old should rarely be used for 
making an argument about current additions s much has changed in the 
past few years.  Using s reference from 2000 (16 years ago), which is 
likely referring to data from 1999 or earlier is completely inappropriate 
for supporting a statement about the "most commonly misused 
substances" as is a 2011 reference as the sole reference for supporting 
the growing concern about the misuse of analgesics.   
The references have been reviewed and additional contemporary work is now cited. As 
described in comment #13, this reference was mistakenly detailed as being from 2000, 
but is no longer used owing to reference number limits. 
 
18 Consistency is important for understanding the article - individuals are 
referred to as "patients" and "people" e.g., lines 17-18: health 
professional in primary care who are likely to come in contact with 
people" - are these "people" not "patients", and lines 19-20, 
"community pharmacy settings with regard to patients with ATM." And 
later on line 27 where "individuals" is used 
For consistency, all references to individuals have been updated to patients throughout 
the article 
19 Line 24: define "snowball recruitment" On reflection we feel ‘snowball recruitment’ was a misleading term as dissemination 
was via public health teams within local authorities, who distributed the survey to 
General Practices and Pharmacies in their area. We have changed the text in lines 21-22 
to describe the recruitment process: 
“…via Local Authority (LA) Public Health teams. Eight of the nine LAs approached agreed 
to do this.”. 
 
20 Line 29-30: the actual name and location for the institutional review 
board should be included. 
We have amended the text accordingly in line 28-29: 
“The study was approved by the Liverpool John Moores University Research Ethics 
Committee. 
 
 
21 Line 60-61: the word "significant" should be reserved for issues that are 
statistically significant, and not simply for issues that the authors believe 
are important. 
We have amended the text as suggested to remove the word significant to read: 
Lines 56-57: “This study contributes further evidence that ATM is an important public 
health issue in the UK” 
Line 57: “findings suggest that there is a sizeable population…” 
22 Line 64: define "z-drugs" To avoid confusion we have updated the text in line 59 to read: 
“hypnotics (e.g. benzodiazepines and similar drugs)” 
23 Line 66: the following statement does not appear supported by the 
data, "suggesting that medicines containing codeine are likely to be of 
concern".  Why is codeine singled out?  Figure 2 shows more suspected 
We thank the reviewer for highlighting this and have removed the line from the 
manuscript. 
 
"addiction issues" with anxiolytics and hypnotics and with strong opioid 
analgesics than with weak opioids (which is where I assume codeine 
fits), and I assume in the group of weak opioids there are opioids in 
addition to codeine in this category. 
24 how much training do GPs and Pharmacists in the UK receive regarding 
addiction, in particular accurate diagnosis, and for treating pain.  If it is 
as limited as it is in US medical schools then there is no reason to put 
much significance at all on these results.  Addition is not an easy issue to 
diagnosis without appropriate training, and without some compassion 
for population.  It is easy to assess a patient taking any of these 
medications as an "addict", especially if they are difficult or problematic 
in any way.  And how is "addiction" seen in the general population - 
what do patients (or people or individuals) interpret as an addiction.  In 
the US anything done frequently is often labeled as an addiction (see 
reference to "automatic teller machine (ATM) addiction" mentioned 
earlier).   
The underpinning premise for this work is around examining the need for additional 
support for patients and healthcare professionals in respect of addiction to medicines – 
a phenomenon that is increasingly being recognised as problematic in the UK and 
elsewhere. Education and training on addiction for health professionals in the UK is 
varied and depends very much on the postgraduate training that individuals have 
undertaken. However, we feel that the key message from this work is that health 
professionals are relatively frequently suspecting addiction to medicines, but in many 
cases they report feeling unable to respond to this. Therefore, while we accept the 
point the reviewer is making regarding the potential inaccuracy of diagnosis, and the 
possibly unwarranted labelling of some behaviours as an addiction, the value that this 
paper adds is around highlighting the need for improving core education for healthcare 
professionals around understanding risks of addiction with respect to medicines, how 
to identify it and how it might be tackled. In revising the manuscript, we have further 
emphasised this point while recognising a limitation of the study being that addiction is 
only suspected and not diagnosed by the health professionals involved. 
25 The abuse of anti-epileptics and neuropathic analgesics are limited in 
the US; there is no justification given in this article for their inclusion in 
this study, and their inclusion likely skews the results. 
Questions about antiepileptic and neuropathic agents (such as gabapentinoids) were 
included in the questionnaire owing to numerous suggestions regarding misuse and 
addiction issues relating to these (Schifano F, D’Offizi S, Piccione M, et al. Is there a 
recreational misuse potential for pregabalin? Analysis of anecdotal online reports in 
comparison with related gabapentin and clonazepam data. Psychotherapy and 
psychosomatics 2011; 80: 118–22 and Kapil V, Green JL, Le Lait M-C, Wood DM, Dargan 
PI. Misuse of the γ-aminobutyric acid analogues baclofen, gabapentin and pregabalin in 
the UK. British Journal of Clinical Pharmacology 2014; 78: 190–1.), as evidenced in a 
recent review article – Smith R V., Havens JR, Walsh SL. Gabapentin misuse, abuse and 
diversion: a systematic review. Addiction 2016; 111: 1160–74. We have now made 
explicit reference to this in the introduction.  
Further, we believe that the fact that substantial numbers of health professionals 
surveyed reported that they suspected addiction to these substances justifies their 
inclusion.  
26 And what about OTC and prescribed stimulants; they are included in 
figure 2, but not discussed,other than being linked to younger 
individuals. And abuse issues associate with their use appears to be the 
As this is a short report, with limited space available, and the study being focussed on 
the broader issues around the overall frequency that addiction to medicine is suspected 
and how this is responded to by health professionals, we have not been able to discuss 
in detail individual substance groups in great depth. 
lowest of all the drugs investigated.  This is contrary to what we are 
seeing in the US, and should be discussed.   
 
REVIEWER 4 
27 In the first paragraph of results and Figures 1 and 2 it needs to be made 
clearer that the frequencies listed ("Weekly or more", "Monthly or 
more" and "Less than Monthly") refer to the frequency of occurrence 
reported by the participants of the item noted (e.g. patient admitting 
addiction) and  not to the frequency of drug use by the patient. I assume 
that "Monthly or more" means occurrence at least once/month, but not 
as frequently as once/week.  If so, that needs to be stated.  If not, why 
does that category not include "Weekly or more"? 
For clarity, frequency categories have been updated in the text and figures to indicate 
that, as the reviewer assumed, “monthly or more” meant occurrence at least once per 
month but not as frequently as once per week. 
28 The numbers referred to in lines 38-42 are referenced to Figure 1.  
However, they do not seem to agree with numbers in the figure (e.g. in 
line 42, 27/63 are reported to have initiated a conversation; however, 
Fig. 1 appears to show that 11 initiated a conversation at least once/wk, 
25 initiated a conversation at least once/month and 27 initiated a 
conversation less than once/month). If the numbers reported in Results 
refer to numbers different from those shown in Fig. 1, that needs to be 
explained. 
We thank the reviewer for highlighting this discrepancy, the number of participants 
reporting initiating a conversation on a less than monthly basis rather than a weekly or 
more frequent basis was reported in the text in lines 36-38. This has now been updated 
and data in the text matches data in figures. 
“However, just (17%, 11/63) reported initiating a conversations, or refusing access to 
medicines (25%, 16/63), on a weekly or more frequent basis” 
29 Were there any guidelines for participants in items to consider in 
making their judgments concerning "Participant suspects addiction" or 
was this just an "opinion" with no qualifiers? 
We have made changes to the text regarding the survey items (lines 23-36) and 
discussion of study limitations (lines 75-88) to address this point. 
30 Is there any information on how many participants were identified in 
each category and perhaps approximately what percentage of the 
patients seen by that participant fell into each category? 
 
We have now added text to make clear that the sample size precluded subgroup 
analysis by job role (lines 27-28). 
 
Figure 1: Frequency of participants reporting patient’s admission and personal suspicion of addiction alongside frequency 
that action is taken 
 
 
Figure 2: Frequency of suspected addiction in patients by medicine group (n=75) 
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